Literature DB >> 29671062

The impact of dietary regimen compliance on outcomes for HNSCC patients treated with radiation therapy.

Rafi Kabarriti1, Amanda Bontempo1, Maria Romano1, Kevin P McGovern1, Alyssa Asaro1, Shankar Viswanathan2, Shalom Kalnicki1, Madhur K Garg3.   

Abstract

OBJECTIVE: To analyze nutritional factors and compliance with dietary recommendations for associations with overall survival (OS) and progression-free survival (PFS) in patients receiving definitive RT for laryngeal and oropharyngeal cancers. MATERIALS/
METHODS: We identified 352 patients with non-metastatic laryngeal (146) and oropharyngeal (206) cancer treated with definitive RT between 2004 and 2013. Disease and patient characteristics, treatment information, sarcopenia based on muscle areas at L3 level on CT, compliance with the nutritional program, and clinical outcomes data were tabulated. Descriptive statistics, Kaplan-Meier survival analysis, and log rank tests were performed, and Cox regression models were used to examine predictors of OS and PFS.
RESULTS: The median follow-up for the entire cohort was 22.86 months. The actuarial rates for OS were 91, 86, and 73% at years 1, 2, and 5, respectively. Of patients with abdominal CT prior to starting RT, 70.9% (112/158) were sarcopenic with a median muscle mass index of 48.2 (range 30.4-70.9) for males and 35.9 (range 24.6-53.2) for females. The majority (85.8%) of patients met with a dietitian during their course of RT and 62.6% of these patients were compliant with the nutritional program. Compliance with the nutritional program resulted in 27% (HR 0.73, 95% CI 0.43-1.26) protection from death (did not reach significance) and 31% (HR 0.69, 95% CI 0.50-0.94) significant protection from disease progression. Higher pretreatment BMI was associated with a lower risk of death (HR 0.94, 95% CI 0.90-0.99) and disease progression (HR 0.96, 95% CI 0.93-0.99).
CONCLUSION: Laryngeal and oropharyngeal cancer patients treated with definitive RT who are compliant with regular dietetic counseling and contact appear to have improved outcomes. TRIAL REGISTRATION: Not applicable.

Entities:  

Keywords:  Compliance; Head and neck cancer; Nutrition; Radiation therapy

Mesh:

Year:  2018        PMID: 29671062     DOI: 10.1007/s00520-018-4198-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  20 in total

Review 1.  Nutrition and physical activity guidelines for cancer survivors.

Authors:  Cheryl L Rock; Colleen Doyle; Wendy Demark-Wahnefried; Jeffrey Meyerhardt; Kerry S Courneya; Anna L Schwartz; Elisa V Bandera; Kathryn K Hamilton; Barbara Grant; Marji McCullough; Tim Byers; Ted Gansler
Journal:  CA Cancer J Clin       Date:  2012-04-26       Impact factor: 508.702

2.  Prognostic factors in advanced head and neck cancer patients undergoing multimodality therapy.

Authors:  R Mick; E E Vokes; R R Weichselbaum; W R Panje
Journal:  Otolaryngol Head Neck Surg       Date:  1991-07       Impact factor: 3.497

3.  Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer.

Authors:  Harriët Jager-Wittenaar; Pieter U Dijkstra; Arjan Vissink; Bernard F A M van der Laan; Rob P van Oort; Jan L N Roodenburg
Journal:  Head Neck       Date:  2010-09-07       Impact factor: 3.147

4.  Pretreatment nutritional status and locoregional failure of patients with head and neck cancer undergoing definitive concurrent chemoradiation therapy.

Authors:  Mary E Platek; Mary E Reid; Gregory E Wilding; Wainwright Jaggernauth; Nestor R Rigual; Wesley L Hicks; Saurin R Popat; Graham W Warren; Maureen Sullivan; Wade L Thorstad; Mohamed K Khan; Thom R Loree; Anurag K Singh
Journal:  Head Neck       Date:  2010-12-15       Impact factor: 3.147

5.  Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma.

Authors:  S Antoun; V E Baracos; L Birdsell; B Escudier; M B Sawyer
Journal:  Ann Oncol       Date:  2010-01-20       Impact factor: 32.976

Review 6.  Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.

Authors:  Brenda Nugent; Sian Lewis; Joe M O'Sullivan
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

7.  Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.

Authors:  Carla M M Prado; Vickie E Baracos; Linda J McCargar; Tony Reiman; Marina Mourtzakis; Katia Tonkin; John R Mackey; Sheryl Koski; Edith Pituskin; Michael B Sawyer
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

Review 8.  The role of dietary counseling and nutrition support in head and neck cancer patients.

Authors:  Mary E Platek
Journal:  Curr Opin Support Palliat Care       Date:  2012-12       Impact factor: 2.302

Review 9.  Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review.

Authors:  Shlomit Strulov Shachar; Grant R Williams; Hyman B Muss; Tomohiro F Nishijima
Journal:  Eur J Cancer       Date:  2016-02-13       Impact factor: 9.162

Review 10.  Nutritional interventions in head and neck cancer patients undergoing chemoradiotherapy: a narrative review.

Authors:  Maurizio Bossola
Journal:  Nutrients       Date:  2015-01-05       Impact factor: 5.717

View more
  8 in total

1.  Low skeletal muscle mass and post-operative complications after surgery for liver malignancies: a meta-analysis.

Authors:  Maximilian Thormann; Jazan Omari; Maciej Pech; Robert Damm; Roland Croner; Aristotelis Perrakis; Alexandra Strobel; Andreas Wienke; Alexey Surov
Journal:  Langenbecks Arch Surg       Date:  2022-05-18       Impact factor: 2.895

Review 2.  Older cancer patients receiving radiotherapy: a systematic review for the role of sarcopenia in treatment outcomes.

Authors:  Nezahat Muge Catikkas; Zumrut Bahat; Meryem Merve Oren; Gulistan Bahat
Journal:  Aging Clin Exp Res       Date:  2022-02-15       Impact factor: 4.481

3.  Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors.

Authors:  Jip M van Elst; Nikki S IJzerman; Ron H J Mathijssen; Neeltje Steeghs; Anna K L Reyners; Jacco J de Haan
Journal:  Support Care Cancer       Date:  2021-11-02       Impact factor: 3.603

4.  The role of acetyl-coA carboxylase2 in head and neck squamous cell carcinoma.

Authors:  Kun Li; Chengcheng Zhang; Lei Chen; Pingping Wang; Yang Fang; Junwei Zhu; Shuo Chen; Juan Du; Bing Shen; Kaile Wu; Yehai Liu
Journal:  PeerJ       Date:  2019-06-11       Impact factor: 2.984

5.  What Factors Affect Changes in Body Composition and Swallowing Function in Patients Hospitalized for Oral Cancer Surgery?

Authors:  Yuko Kagifuku; Haruka Tohara; Yoko Wakasugi; Chiaki Susa; Ayako Nakane; Mizue Toyoshima; Koichi Nakakuki; Yuji Kabasawa; Hiroyuki Harada; Shunsuke Minakuchi
Journal:  Clin Interv Aging       Date:  2020-01-06       Impact factor: 4.458

6.  Nutritional interventions in patients with head and neck cancer undergoing chemoradiotherapy: Current practice at the Dutch Head and Neck Oncology centres.

Authors:  Annemieke Kok; Carlijn van der Lugt; Marja J Leermakers-Vermeer; Nicole M de Roos; Caroline M Speksnijder; Remco de Bree
Journal:  Eur J Cancer Care (Engl)       Date:  2021-10-12       Impact factor: 2.328

7.  Role of Sarcopenia in Advanced Malignant Cutaneous Melanoma Treated with Immunotherapy: A Meta-Analysis.

Authors:  Alexey Surov; Hans-Jonas Meyer; Andreas Wienke
Journal:  Oncology       Date:  2022-07-11       Impact factor: 3.734

8.  Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis.

Authors:  Alexey Surov; Andreas Wienke
Journal:  Ther Adv Med Oncol       Date:  2021-05-13       Impact factor: 8.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.